rhodamine 123 has been researched along with 1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbier, M; Boumendjel, A; Boutonnat, J; Hadjeri, M; Mariotte, AM; Ronot, X | 1 |
1 other study(ies) available for rhodamine 123 and 1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium
| Article | Year |
|---|---|
Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Chromones; Daunorubicin; Drug Resistance, Multiple; Drug Synergism; Flavonoids; Fluorescent Dyes; Humans; Necrosis; Piperazines; Quinolinium Compounds; Rhodamine 123; Thiazoles; Tumor Cells, Cultured | 2003 |